Chemical synthesis study demonstrates routes to sialyl-glucopyranosyl and hexopyranosyl ceramides, facilitating access to complex glycosphingolipid probes.
Sialyl-α(2→3)- or sialyl-α(2→6)-β-D-glucopyranosyl- and 2-acetamido-2-deoxy-β-D-hexopyranosyl ceramides or the analogs at the lipophilic residue were synthesized. 2-(Trimethylsilyl)ethyl sialyl-α(2→6)-β-D-gluco-, 2-acetamido-2-deoxy-β-D-gluco-, 2-acetamido-2-deoxy-β-D-galacto- and sialyl-α(2→3)-2-acetamido-2-deoxy-β-D-gluco-pyranoside derivatives (1–4) were converted into the corresponding α-trichloroacet-imidate 8 or oxazolines 14,15 and 23 which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-l,3-diol (5) or 2-azidoethanol, gave the corresponding β-glycosides 9,16,19 and 24, respectively. Finally, the p-glycosides 9, 16, 19 and 24 were transformed, via selective reduction of the azide group, condensation with octa-decanoic acid or 2-tetradecylhexadecanoic acid (6), O-deacylation and hydrolysis of the methyl ester group, into the title compounds.
No takes yet. Share an insight, caveat, or question.
Hasegawa et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: